Savings End in...
Achieve Operational Excellence, Regulatory Compliance & Minimize Risk in R&D & Manufacturing Sites
Navigating the Future of Environmental, Health & Safety in Biopharma
As the biopharma industry evolves with rapid advancements in drug development, manufacturing, and research, EHS leaders are tasked with safeguarding employee health, maintaining a culture of safety, and addressing environmental concerns. Navigating these challenges while meeting sustainability goals and mitigating risks has become essential for operational success. EHS professionals must continuously adapt to this dynamic landscape to protect their most valuable asset: their workforce.
The 2nd EHS for Biopharma East Summit is an essential event for EHS professionals working in the biopharma industry, focused on overcoming the sector's unique regulatory and operational challenges. With over 100+ attendees, this summit will provide valuable insights on navigating evolving regulations, optimizing safety protocols, and enhancing environmental stewardship. Whether your goal is to strengthen safety culture, reduce incidents, or achieve sustainability targets, the summit offers the tools, knowledge, and networking opportunities necessary to elevate EHS practices.
Gain continuing education credits as you hear from EHS&S leaders at large global pharma companies like Sanofi, AstraZeneca, BMS, Astellas, Charles River, Amgen, CDMOs and CROs and small biotechs.
Earn credits from BCSP, ABSA & CIH!
World-Class Speaker Faculty Includes:
Previously Attending Companies Include:
"This conference was outstanding. I particularly enjoyed the biopharmaceuticals industry focus number and diversity of attendees, all the topics and speakers.”
- Global Head of Environment, Health, and Safety & Sustainability, Ultragenyx Pharmaceutical
"This conference was outstanding. I particularly enjoyed the biopharmaceuticals industry focus number and diversity of attendees, all the topics and speakers.”
- Global Head of Environment, Health, and Safety & Sustainability, Ultragenyx Pharmaceutical